1st Day of Advent...

Wishing all of our wonderful supporters a fabulous Christmas and New Year!

Click on the tab below to listen to Tom's song - 'The First Day of Christmas...' - a humorous take on those Parkinson's meds !

The_First_Day_of_Xmas.mp3

Latest

Celebrating Tom - an evening of tributes and triumphs.

On 12th September, we celebrated the life and achievements of the wonderful Tom Isaacs - co-founder of The Cure Parkinson's Trust. Tom's incredible legacy remains at the absolute heart of the Trust.
The 'Tom Isaacs Award'

The Van Andel Research Institute and The Cure Parkinson’s Trust will introduce 'The Tom Isaacs Award' to be presented at the annual Grand Challenges in Parkinson’s and Rallying to the Challenge meeting on 27th & 28th September in Grand Rapids, Michigan.
The Tom Isaacs Charity Golf Day, Denham Golf Club

Our annual fundraising golf day will be taking place on Thursday 19th October 2017 at Denham Golf Club, Buckinghamshire.
Major gifts

24th Day of Advent

It's Christmaaaaaas!
21st Day of Advent

A research paper published in the Journal of Parkinson's Disease in April discussed a clinical trial in Parkinson's disease (PD) using parthenogenetic stem cells for transplantation into PD patients.
18th Day of Advent

In April and October our research update meetings saw many of our supporters attending to hear our latest research news...
14th Day of Advent...

In September, CPT announced another drug to be trialled in the Linked Clinical Trials programme. Liraglutide, a drug which stimulates the release of insulin, is being trialled for its neuroprotective effects.
13th Day of Advent...

In May and October this year, CPT had the privilege of being the beneficiary of both The Gulls Eggs and The Grouse and Grape fundraising luncheons...
12th Day of Advent...

In January, CPT announced the launch of the Simvastatin trial under our Linked Clinical Trials programme.
11th Day of Advent...

The City-based philanthropy group - The October Club - chose CPT to be the beneficiary of their annual fundraising dinner at The Savoy, London...
9th Day of Advent...

The 'Prudential RideLondon 46' took place in July and our team of cyclists sped around London's iconic landmarks.
8th Day of Advent...

**New data published** yesterday shows MSDC-0160 preserves critical brain function in laboratory models of Parkinson’s.
7th Day of Advent...

CPT are so grateful to those supporters who selflessly asked for donations to come our way instead of receiving birthday gifts for themselves!

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Trials - Repurposed drugs

Our Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop, or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Our story
Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic?

A research paper published in the Journal of Parkinson's Disease (Spring 2016) discusses an impending clinical trial in Parkinson's disease (PD) using parthenogenetic stem cells.
Apply for Funding
Breaking News: Diabetes Drug Shows Potential as Disease-Modifying Therapy for Parkinson’s

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
The NAC Trial - the facts
Study links Parkinson's disease to Gut Bacteria

A new study finds that people with Parkinson's disease appear to have distinctly different gut bacteria.